azacrin has been researched along with epothilone b in 1 studies
| Studies (azacrin) | Trials (azacrin) | Recent Studies (post-2010) (azacrin) | Studies (epothilone b) | Trials (epothilone b) | Recent Studies (post-2010) (epothilone b) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 305 | 27 | 129 |
| Protein | Taxonomy | azacrin (IC50) | epothilone b (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.0035 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.0035 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
1 other study(ies) available for azacrin and epothilone b
| Article | Year |
|---|---|
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |